Optimal methods to characterize the G93A mouse model of ALS

In the present study, we used the SOD1 (G93A) mutant transgenic mice as a model of amyotrophic lateral sclerosis (ALS). This model is widely used as a laboratory tool to study experimental treatments in vivo for ALS to investigate new therapeutic strategies for this neurodegenerative disease. Such studies require the objective quantification of different parameters while mice develop the disease. We have applied a battery of different and specific tests: scoring of motor deficits by a trained observer, weighing, survival measure, hanging wire test, rotarod task and electromyography, most of them commonly used to evaluate G93A animals. We have critically compared these methods, showing the significant influence of gender on the onset of symptoms, and the optimal moment to apply each test. These results should be taken into account in future therapeutic assays on this ALS model.

[1]  J. Veldink,et al.  Sexual differences in onset of disease and response to exercise in a transgenic model of ALS , 2003, Neuromuscular Disorders.

[2]  Honghu Liu,et al.  Estimating the Area under a Receiver Operating Characteristic Curve For Repeated Measures Design , 2003 .

[3]  Michel Kliot,et al.  Assessing disease onset and progression in the SOD1 mouse model of ALS , 2003, Neuroreport.

[4]  R. Pabst,et al.  Behavioral phenotyping of mice in pharmacological and toxicological research. , 2003, Experimental and toxicologic pathology : official journal of the Gesellschaft fur Toxikologische Pathologie.

[5]  J. Rothstein,et al.  Cyclooxygenase 2 inhibition protects motor neurons and prolongs survival in a transgenic mouse model of ALS , 2002, Annals of neurology.

[6]  Emma Domínguez Alonso,et al.  Análisis de las curvas receiver-operating characteristic: un método útil para evaluar procederes diagnósticos , 2002 .

[7]  N. Shibata.  Transgenic mouse model for familial amyotrophic lateral sclerosis with superoxide dismutase‐1 mutation , 2001, Neuropathology : official journal of the Japanese Society of Neuropathology.

[8]  Jacqueline N. Crawley,et al.  What's Wrong With My Mouse?: Behavioral Phenotyping of Transgenic and Knockout Mice , 2000 .

[9]  J. Crawley.  Behavioral phenotyping of transgenic and knockout mice: experimental design and evaluation of general health, sensory functions, motor abilities, and specific behavioral tests 1 Published on the World Wide Web on 2 December 1998. 1 , 1999, Brain Research.

[10]  R. Barohn,et al.  Toward earlier diagnosis of amyotrophic lateral sclerosis , 1998, Neurology.

[11]  M. Gurney,et al.  A low expressor line of transgenic mice carrying a mutant human Cu,Zn superoxide dismutase (SOD1) gene develops pathological changes that most closely resemble those in human amyotrophic lateral sclerosis , 1997, Acta Neuropathologica.

[12]  M. Gurney,et al.  Progressive motor neuron impairment in an animal model of familial amyotrophic lateral sclerosis , 1997, Muscle & nerve.

[13]  I. Fridovich,et al.  Superoxide radical and superoxide dismutases. , 1995, Annual review of biochemistry.

[14]  M. Gurney,et al.  Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation. , 1994, Science.

[15]  J. Haines,et al.  Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis , 1993, Nature.